Lurbinectedin is under clinical development by Pharma Mar and currently in Phase II for Sarcomas. According to GlobalData, Phase II drugs for Sarcomas have a 27% phase transition success rate (PTSR) ...

Lurbinectedin is under clinical development by Jazz Pharmaceuticals and currently in Phase II for Metastatic Transitional (Urothelial) Tract Cancer. According to GlobalData, Phase II drugs for ...

including lung (36%), adrenal (17%), bone (10%), lymph nodes (10%), bone with a soft tissue component (6%), lung with at least 1 hilar lymph node (4%), retroperitoneum (5%), brain (2%), pancreas ...

Teratomas are embryonal tumors that arise in the germ cells and contain different types of tissues, including bone, teeth, hair, and muscle. 1 Scientists have classified teratomas as a rare type ...